96940 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Nerve growth factor [NGF]
PRODUCTION OF NERVE GROWTH FACTOR (NGF) AND OF MUTEINS THEREOF
#2METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION
#3Nucleic Acid Molecule, Vector, Recombinant Cells, and Drug for Treating Central Nervous System Disease
#4TROPOMYOSIN KINASE RECEPTOR (TRK) LIGANDS AS THERAPEUTICS TO SUPPORT LIVER REGENERATION
#5BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES
#6BLOOD-BRAIN BARRIER TRANSLOCATING PEPTIDES AND RELATED MOLECULES AND METHODS OF USE THEREOF
#7FUSION PROTEIN OF SERUM ALBUMIN AND PHYSIOLOGICALLY-ACTIVE PROTEIN
#8NERVE GROWTH FACTOR AND METHODS OF USE THEREOF FOR NEURODEVELOPMENTAL DISABILITIES ASSOCIATED WITH NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY
#9AGENT FOR TREATMENT OF DERMATOLOGICAL DISORDERS
#10PLASMID ENCODING AN INSULIN PEPTIDE AND Fc FUSION PROTEIN
#11PLASMID ENCODING A NGF AND Fc FUSION PROTEIN
#12PLASMID ENCODING A TLR3 AND Fc FUSION PROTEIN
#13PLASMID ENCODING A DNAse I AND Fc FUSION PROTEIN
#14PLASMID ENCODING A TLR9 AND Fc FUSION PROTEIN
#15METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING TEAR FILM COMPOSITION TO TREAT CORNEAL DEFECTS
#16FUSION PROTEINS FOR TREATING CNS DISEASES
#17THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN
#18ACTIVE IMMUNIZATION FOR REDUCING OSTEOARTHRITIC, NEUROPATHIC, AND CANCER PAIN
#19RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
#20RECOMBINANT PROTEIN OF NERVE GROWTH FACTOR MUTANT AND USE THEREOF
#21LONG-ACTING NERVE GROWTH FACTOR POLYPEPTIDES AND USES THEREOF
#22Fusion Protein Containing BDNF
#23COMPOUNDS AND METHODS FOR TREATING PAIN
#24GENE THERAPY FOR WET AGE-RELATED MACULAR DEGENERATION USING IPSC-DERIVED CELLS AS VECTORS
#25NERVE GROWTH FACTOR FUSION PROTEIN, PREPARATION METHOD AND USE THEREOF
#26BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#27NERVE GROWTH FACTOR FUSION PROTEIN, PREPARATION METHOD AND USE THEREOF
#28RECOMBINANT CHO CELL, CONSTRUCTION METHOD THEREFOR, AND DETECTION SYSTEM AND METHOD USING SAME
#29RETRO-INVERSO PEPTIDES
#30COMPOSITION AND METHOD FOR TREATING NEUROPATHY
#31NGF VARIANTS, PRODUCTION, COMPOSITIONS, AND THERAPEUTIC USES
#32NERVE GROWTH FACTOR MUTANT
#33ANTI-HUMAN NERVE GROWTH FACTOR ANTIBODY
#34PREPARATION METHOD FOR SILK FIBROIN NERVE GRAFT FUSED WITH NT3
#35METHOD FOR PREPARING RECOMBINANT HUMAN NERVE GROWTH FACTOR
#36COMPOSITIONS AND METHODS FOR RECOMBINANT NERVE GROWTH FACTOR
#37NEUROTROPHIC FACTOR PROTEIN CONJUGATES AND RELATED EMBODIMENTS
#38Recombinant proteins and their therapeutic uses
#39MODIFIED RECOMBINANT HUMAN NERVE GROWTH FACTOR AND METHOD FOR PREPARING THE SAME
#40NERVE GROWTH FACTOR MUTANT
#41AGENT FOR TREATMENT OF DERMATOLOGICAL DISORDERS
#42Compounds and methods for treating pain
#43NSP-INTERLEUKIN-10 PROTEINS AND USES THEREOF
#44Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody
#45Anti-TrkB agonist antibodies binding to D1 domain of TrkB
#46NEUROTROPHIN MUTANTS AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS
#47Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
#48PRODUCTION OF NERVE GROWTH FACTOR (NGF) AND OF MUTEINS THEREOF
#49METHOD FOR PREPARING HIGHLY PURE RHNGF
#50Polypeptide and antibody bound to polypeptide
#51Nucleic acids encoding p75NTR neurotrophin binding proteins
#52A NEUROTROPHIC PEPTIDE FOR THE THERAPEUTIC TREATMENT OF NEURODEGENERATIVE AND/OR INFLAMMATORY DISEASES
#53CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#54INTRON FOR INCREASING EXPRESSION LEVEL OF RHNGF
#55METHOD FOR REMOVING N-TERMINAL TRUNCATED AND ABNORMAL VARIANTS IN RHNGF
#56Method for dynamically removing recombinant human nerve growth factor precursor by hydrophobic interaction chromatography
#57USE OF CEREBROLYSIN
#58Methods and materials for NT-3 gene therapy
#59INHIBITOR OF ASTROCYTE TNF ALPHA FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES
#60Nerve growth factor fusion protein, preparation method and use thereof
#61Nsp-interleukin-10 proteins and uses thereof
#62Compounds and methods for treating pain
#63Genetic construct
#64NOVEL PRONGF MUTANTS AND USES THEREOF IN THE PRODUCTION OF BETA-NGF
#65Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma
#66Method of constructing zebrafish mutants
#67AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#68Recombinant polypeptide production methods
#69Nerve growth factor mutant
#70INHIBITOR OF ASTROCYTE TNF ALPHA FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES
#71METHODS OF PRODUCING AND PURIFYING MATRIX-BINDING FUSION PROTEINS BY ION-EXCHANGE CHROMATOGRAPHY
#72AAV with unique capsid protein VP1 and methods of using for treatment
#73Genetic construct
#74Compounds and methods for treating pain
#75Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#76Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#77Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody
#78P75NTR binding protein-Fc fusion protein and methods of treating pain
#79Recombinant proteins and their therapeutic uses
#80Therapeutic use of p75NTR neurotrophin binding protein
#81proNGF mutants and uses thereof for the preparation of NGF mutants
#82Methods for treating back or neck pain caused by NGF using a therapeutic agent comprising REN-1820, ALE-0540 and capsaicin
#83CHIMERIC PROTEIN
#84Therapeutic use of a growth factor, METRNL
#85Chimeric antigen receptors
#86AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#87Method of treating intraocular tissue pathologies with nerve growth factor
#88Recombinant polypeptide production methods
#89Methods of treating neuropathic pain with specific binding members for NGF
#90ProNGF mutants and uses thereof in the production of beta-NGF
#91Therapeutic use of a growth factor, METRNL
#92Synthetic analogues of neural regeneration peptides
#93Compounds and methods for treating pain
#94Modulation of activity of neurotrophins
#95Neurturin molecules
#96Neurturin molecules
#97ProNGF mutants and uses thereof in the production of beta-NGF
#98Therapeutic use of p75NTR neurotrophin binding protein
#99ENGINEERED PEPTIDE (EP)-DIRECTED PROTEIN INTERCELLULAR DELIVERY SYSTEM AND USES THEREOF
#100Activated collagen scaffold materials and their special fused active restoration factors
#101Activated collagen scaffold materials and their special fused active restoration factors
#102Recombinant proteins and their therapeutic uses
#103Suppression of prostate cancer using a targeted clostridial neurotoxin
#104AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#105Post-translationally modified neurotrophin antibodies
#106Ciliary neurotrophic factor variants
#107ISOLATED NUCLEIC ACID MOLECULE ENCODING A NEUROTROPHIC GROWTH FACTOR
#108Treatment of obesity
#109NEURTURIN MOLECULES
#110Therapeutic use of a growth factor, METRNL
#111Synthetic analogues of neural regeneration peptides
#112Modulation of activity of neurotrophins
#113Compounds for Delivery of Therapeutic And Imaging Moieties to Nerve Cells
#114NOVEL NEUROTROPHIC FACTORS
#115FUSION PROTEINS FOR DELIVERY OF GDNF AND BDNF TO THE CENTRAL NERVOUS SYSTEM
#116Method of treating intraoccular tissue pathologies with nerve growth factor
#117CLOSTRIDIAL TOXIN DERIVATIVES ABLE TO MODIFY PERIPHERAL SENSORY AFFERENT FUNCTIONS
#118Modulation of activity of neurotrophins
#119METHODS FOR TREATING PARKINSON'S DISEASE AND OTHER DISORDERS OF DOPAMINERGIC NEURONS OF THE BRAIN
#120Nerve Growth Factor Conjugates and Uses Thereof
#121Methods of treating neuropathic pain with an environ polypeptide
#122Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
#123GRAFT COMPOSITION FOR NEURAL TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF
#124Therapeutic use of a growth factor, METRNL
#125Synthetic analogues of neural regeneration peptides
#126Transgenic rodents having NGF beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins
#127Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#128Neurotrophic factors and methods of use thereof
#129GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
#130Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains
#131TREATMENT OF OBESITY
#132Method for obtaining active pro-NGF and beta-NGF
#133Pantropic neurotrophic factors
#134ISOLATED MODIFIED HUMAN CHORIONIC GONADOTROPIN PROTEINS
#135POST-TRANSLATIONALLY MODIFIED NEUROTROPHINS
#136Biomarkers for schizophrenia
#137Heterodimeric peptide compounds displaying NGF activity and their use to treat neurodegenerative disorders
#138Activated collagen scaffold materials and their special fused active restoration factors
#139Compounds for delivery of therapeutic and imaging moieties to nerve cells
#140Treatment methods using NGF variants
#141Clostridial toxin derivatives able to modify peripheral sensory afferent functions
#142Therapeutic use of growth factors,nsg29 and nsg31
#143CRMP4b inhibitory peptide
#144Clostridial toxin derivatives able to modify peripheral sensory afferent functions
#145Human Therapeutic Cells Secreting Nerve Growth Factor
#146Methods of activating RET receptor tyrosine kinase using neurotrophic factors
#147Method for the Production of Biologically Active Rhngf
#148Neurotrophic growth factor, enovin
#149Specific binding members for NGF
#150Stable mutated pro nerve growth factors
#151Modulation of activity of neurotrophins
#152Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
#153Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
#154Methods of treating pain using neurotrophic factors
#155Animal model for schizophrenia
#156Therapeutic agent for NGF
#157Therapeutic agent for NGF
#158Motoneuronotrophic factor gene sequences
#159Pantropic neurothrophic factors
#160Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-α
#161Chimeric protein
#162Method for treating or preventing a neural disorder with a neurotrophic growth factor
#163Clostridial toxin derivatives able to modify peripheral sensory afferent functions